Delirium at the End of Life

被引:16
|
作者
Agar, Meera [1 ]
Bush, Shirley H. [2 ,3 ,4 ,5 ]
机构
[1] Univ Technol Sydney, Fac Hlth, IMPACCT Improving Palliat Aged & Chron Care Clin, Bldg 10,Level 3,235 Jones St, Ultimo, NSW 2007, Australia
[2] Ottawa Hosp, Gen Campus,501 Smyth Rd,Box 206, Ottawa, ON K1H 8L6, Canada
[3] Bruyere Res Inst, 85 Primrose Ave, Ottawa, ON K1R 6M1, Canada
[4] Ottawa Hosp, Res Inst, 053 Carling Ave, Ottawa, ON K1Y 4E9, Canada
[5] Ottawa Hosp, Bruyere Continuing Care, Palliat Care, 43 Bruyere St, Ottawa, ON K1N 5C8, Canada
关键词
Delirium; Delirium pathophysiology; Delirium screening; Delirium prevention; Antipsychotics; Benzodiazepines; Palliative care; End of life; PALLIATIVE CARE; SUBSYNDROMAL DELIRIUM; ADVANCED CANCER; TERMINALLY-ILL; DEMENTIA; PLACEBO; HALOPERIDOL; VALIDATION; PREDICTORS; EFFICACY;
D O I
10.1016/j.mcna.2020.01.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Delirium is a prevalent acute neurocognitive condition in patients with progressive life-limiting illness. Delirium remains underdetected; a systematic approach to screening is essential. Delirium at the end of life requires a comprehensive assessment. Consider the potential for reversibility, illness trajectory, patient preference, and goals of care before proceeding with investigations and interventions. Management should be interdisciplinary, and nonpharmacologic therapy is fundamental. For patients with refractory and severe agitation or perceptual disturbance, judicious use of medication may also be required. Carers and family should be seen as partners in care and be involved in shared decision making about care.
引用
收藏
页码:491 / +
页数:12
相关论文
共 50 条
  • [1] Delirium at the end of life
    Agar, Meera R.
    AGE AND AGEING, 2020, 49 (03) : 337 - 340
  • [2] Pharmacologic Management of End-of-Life Delirium: Translating Evidence into Practice
    Hui, David
    Cheng, Shao-Yi
    Paiva, Carlos Eduardo
    CANCERS, 2024, 16 (11)
  • [3] Are common delirium assessment tools appropriate for evaluating delirium at the end of life in cancer patients?
    Uchida, Megumi
    Morita, Tatsuya
    Akechi, Tatsuo
    Yokomichi, Naosuke
    Sakashita, Akihiro
    Hisanaga, Takayuki
    Matsui, Takashi
    Ogawa, Asao
    Yoshiuchi, Kazuhiro
    Iwase, Satoru
    PSYCHO-ONCOLOGY, 2020, 29 (11) : 1842 - 1849
  • [4] Drugs, delirium, and ethics at the end of life
    Thomas, Columba
    Alici, Yesne
    Breitbart, William
    Bruera, Eduardo
    Blackler, Liz
    Sulmasy, Daniel P.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2024, 72 (07) : 1964 - 1972
  • [5] Delirium and agitation at the end of life
    Hosker, Christian M. G.
    Bennett, Michael I.
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 353
  • [6] A Relational Ethical Approach to End-of-Life Delirium
    Wright, David Kenneth
    Brajtman, Susan
    Macdonald, Mary Ellen
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2014, 48 (02) : 191 - 198
  • [7] Anticholinergic load and delirium in end-of-life patients
    Pasina, Luca
    Rizzi, Barbara
    Nobili, Alessandro
    Recchia, Angela
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (09) : 1419 - 1424
  • [8] Prevalence of Delirium in End-of-Life Palliative Care Patients: An Observational Study
    Recchia, Angela
    Rizzi, Barbara
    Favero, Alessandra
    Nobili, Alessandro
    Pasina, Luca
    MEDICAL PRINCIPLES AND PRACTICE, 2022, 31 (02) : 118 - 124
  • [9] Treatment of Positive Urine Cultures at End-of-Life and the Effect on Terminal Delirium Management
    Latuga, Natalie M.
    Grant, Pei C.
    Levy, Kathryn
    Luczkiewicz, Debra L.
    AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2022, 39 (09) : 1014 - 1022
  • [10] Palliative sedation for delirium management at the end of life
    Roider-Schur, Sophie
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2020, 13 (01) : 93 - 97